These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 2738895)
1. The importance of the orientation of the C9 substituent to cannabinoid activity. Reggio PH; Greer KV; Cox SM J Med Chem; 1989 Jul; 32(7):1630-5. PubMed ID: 2738895 [TBL] [Abstract][Full Text] [Related]
2. Investigation of the role of the phenolic hydroxyl in cannabinoid activity. Reggio PH; Seltzman HH; Compton DR; Prescott WR; Martin BR Mol Pharmacol; 1990 Dec; 38(6):854-62. PubMed ID: 2174506 [TBL] [Abstract][Full Text] [Related]
3. A rational search for the separation of psychoactivity and analgesia in cannabinoids. Reggio PH; McGaughey GB; Odear DF; Seltzman HH; Compton DR; Martin BR Pharmacol Biochem Behav; 1991 Nov; 40(3):479-86. PubMed ID: 1806940 [TBL] [Abstract][Full Text] [Related]
4. Characterization of a region of steric interference at the cannabinoid receptor using the active analog approach. Reggio PH; Panu AM; Miles S J Med Chem; 1993 Jun; 36(12):1761-71. PubMed ID: 8510104 [TBL] [Abstract][Full Text] [Related]
5. Solid state 2H-NMR as a method for determining the orientation of cannabinoid analogs in membranes. Yang DP; Banijamali A; Charalambous A; Marciniak G; Makriyannis A Pharmacol Biochem Behav; 1991 Nov; 40(3):553-7. PubMed ID: 1806945 [TBL] [Abstract][Full Text] [Related]
6. Importance of the C-1 substituent in classical cannabinoids to CB2 receptor selectivity: synthesis and characterization of a series of O,2-propano-delta 8-tetrahydrocannabinol analogs. Reggio PH; Wang T; Brown AE; Fleming DN; Seltzman HH; Griffin G; Pertwee RG; Compton DR; Abood ME; Martin BR J Med Chem; 1997 Sep; 40(20):3312-8. PubMed ID: 9379452 [TBL] [Abstract][Full Text] [Related]
7. Investigation of the intrinsic cannabinoid activity of hemp-derived and semisynthetic cannabinoids with β-arrestin2 recruitment assays-and how this matters for the harm potential of seized drugs. Janssens LK; Van Uytfanghe K; Williams JB; Hering KW; Iula DM; Stove CP Arch Toxicol; 2024 Aug; 98(8):2619-2630. PubMed ID: 38735004 [TBL] [Abstract][Full Text] [Related]
8. Evidence of 11-Hydroxy-hexahydrocannabinol and 11-Nor-9-carboxy-hexahydrocannabinol as Novel Human Metabolites of Δ Falck Jørgensen C; Schou Rasmussen B; Linnet K; Thomsen R Metabolites; 2023 Nov; 13(12):. PubMed ID: 38132851 [TBL] [Abstract][Full Text] [Related]
9. Effects of cannabinoids on levels of acetylcholine and choline and on turnover rate of acetylcholine in various regions of the mouse brain. Tripathi HL; Vocci FJ; Brase DA; Dewey WL Alcohol Drug Res; 1987; 7(5-6):525-32. PubMed ID: 3620017 [TBL] [Abstract][Full Text] [Related]
10. Conformational analysis and molecular modeling of 1-phenyl-, 4-phenyl-, and 1-benzyl-1,2,3,4-tetrahydroisoquinolines as D1 dopamine receptor ligands. Charifson PS; Bowen JP; Wyrick SD; Hoffman AJ; Cory M; McPhail AT; Mailman RB J Med Chem; 1989 Sep; 32(9):2050-8. PubMed ID: 2527994 [TBL] [Abstract][Full Text] [Related]
11. Structure-activity relationships defining the ACD-tricyclic cannabinoids: cannabinoid receptor binding and analgesic activity. Melvin LS; Milne GM; Johnson MR; Wilken GH; Howlett AC Drug Des Discov; 1995 Nov; 13(2):155-66. PubMed ID: 8872458 [TBL] [Abstract][Full Text] [Related]
12. Stereospecific elimination of deuterium as a method for determining the stereochemistry of a number of metabolites of the tetrahydrocannabinols. Harvey DJ Biomed Mass Spectrom; 1980 Jan; 7(1):28-34. PubMed ID: 6249411 [TBL] [Abstract][Full Text] [Related]
13. Pharmacological profile of a series of bicyclic cannabinoid analogs: classification as cannabimimetic agents. Compton DR; Johnson MR; Melvin LS; Martin BR J Pharmacol Exp Ther; 1992 Jan; 260(1):201-9. PubMed ID: 1309872 [TBL] [Abstract][Full Text] [Related]
14. Structure-activity analysis of anandamide analogs: relationship to a cannabinoid pharmacophore. Thomas BF; Adams IB; Mascarella SW; Martin BR; Razdan RK J Med Chem; 1996 Jan; 39(2):471-9. PubMed ID: 8558515 [TBL] [Abstract][Full Text] [Related]
15. Identification of hexahydrocannabinol (HHC), dihydro-iso-tetrahydrocannabinol (dihydro-iso-THC) and hexahydrocannabiphorol (HHCP) in electronic cigarette cartridge products. Tanaka R; Kikura-Hanajiri R Forensic Toxicol; 2024 Jan; 42(1):71-81. PubMed ID: 37365398 [TBL] [Abstract][Full Text] [Related]
16. Studies Pertaining to the Emerging Cannabinoid Hexahydrocannabinol (HHC). Nasrallah DJ; Garg NK ACS Chem Biol; 2023 Sep; 18(9):2023-2029. PubMed ID: 37578929 [TBL] [Abstract][Full Text] [Related]
17. Comparative molecular dynamics simulations of the potent synthetic classical cannabinoid ligand AMG3 in solution and at binding site of the CB1 and CB2 receptors. Durdagi S; Reis H; Papadopoulos MG; Mavromoustakos T Bioorg Med Chem; 2008 Aug; 16(15):7377-87. PubMed ID: 18595717 [TBL] [Abstract][Full Text] [Related]
18. Chronic cannabinoid administration alters cannabinoid receptor binding in rat brain: a quantitative autoradiographic study. Oviedo A; Glowa J; Herkenham M Brain Res; 1993 Jul; 616(1-2):293-302. PubMed ID: 8395305 [TBL] [Abstract][Full Text] [Related]
19. Hexahydrocannabinol (HHC) and Δ Durydivka O; Palivec P; Gazdarica M; Mackie K; Blahos J; Kuchar M Sci Rep; 2024 Apr; 14(1):9181. PubMed ID: 38649680 [TBL] [Abstract][Full Text] [Related]
20. Prostaglandins and cannabis. XII. The effect of cannabinoid structure on the synthesis of prostaglandins by human lung fibroblasts. Burstein S; Hunter SA; Ozman K Mol Pharmacol; 1983 Jan; 23(1):121-6. PubMed ID: 6865895 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]